A preliminary investigation on the possible association between diminished copper availability and non-alcoholic fatty liver disease in epileptic patients treated with valproic acid

BACKGROUND: Patients treated with valproic acid (VPA) present a high incidence of non-alcoholic fatty liver disease (NAFLD) (around 61%). Several recent studies suggest that low copper stores could be associated with NAFLD, and a significant decrease of copper availability in VPA-treated patients ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Lampon, Natalia, Tutor, J. Carlos
Formato: Texto
Lenguaje:English
Publicado: Informa Healthcare 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3078546/
https://www.ncbi.nlm.nih.gov/pubmed/21190397
http://dx.doi.org/10.3109/03009734.2010.545898

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3078546/
https://www.ncbi.nlm.nih.gov/pubmed/21190397
http://dx.doi.org/10.3109/03009734.2010.545898

Ejemplares similares